Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutation

Michael Drumm, Jessica W. Templer, Matthew Tate, Lawrence J Jennings, Craig Horbinski*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Article numbervdac004
JournalNeuro-Oncology Advances
Issue number1
StatePublished - Jan 1 2022


  • IDH1 mutation
  • recurrence
  • seizure
  • survival

ASJC Scopus subject areas

  • Clinical Neurology
  • Oncology
  • Surgery

Cite this